Linked Data API

Show Search Form

Search Results

1670388
registered interest false more like this
date less than 2023-11-15more like thismore than 2023-11-15
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cancer: Diagnosis more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, if she will take steps to ensure non-stageable cancers are included in the NHS early diagnosis target. more like this
tabling member constituency North East Hampshire remove filter
tabling member printed
Mr Ranil Jayawardena more like this
uin 2191 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-11-22more like thismore than 2023-11-22
answer text <p>The NHS Long Term Plan set an ambition that, by 2028, the proportion of cancers diagnosed at stages 1 and 2 will rise from around half now to three-quarters of cancer patients. Achieving this will mean that, from 2028, 55,000 more people each year will survive their cancer for at least five years after diagnosis. Due to the nature of the ambition, this only includes stageable cancers.</p><p>To find and diagnosed all cancers earlier, NHS England is streamlining cancer pathways to support diagnosis within 28 days by implementing non-symptom specific (NSS) pathways for patients who present with non-specific symptoms that can indicate several cancers, as well as implementing timed cancer pathways.</p><p>Since 2019, cancer alliances have been developing new dedicated urgent diagnostic pathways for these patients so that every cancer patient with concerning, but non-specific symptoms, gets the right tests at the right time in as few visits as possible. By March 2024, the NSS programme will achieve full population coverage across England for non-specific symptom pathways as set out in the 2023/24 NHS Planning Guidance.</p>
answering member constituency Pendle more like this
answering member printed Andrew Stephenson more like this
question first answered
remove filter
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4498
label Biography information for Mr Ranil Jayawardena more like this